Atlas Trials

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

Clinical trial NCT04550481 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04550481
Sponsor
Northwestern University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular CarcinomaNonalcoholic Steatohepatitis
Start date
2021-05-11
Primary completion
2025-08-08
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.